A closer look at the impact of COVID-19 on cardio-oncology
In response to the COVID-19 pandemic, Lauren Baldassarre, MD, and members of the Cardio-Oncology and Imaging Councils of the American College of Cardiology shared recommendations regarding the cardiovascular care of COVID-19-positive patients.
Can a cancer drug treat a rare cardiac disease?
A study by a Yale scientis suggests that dasatinib and similar drugs at low doses could be effective treatment for cardiovascular defects related to Noonan syndrome (NS), a genetic disorder that results in severe heart defects, and should be considered for clinical trials.
Renalase: uncloaking melanoma cancer cells
Eleven years ago, Yale scientist Gary Desir MD and his team were conducting heart disease research when they discovered a naturally occurring protein circulating at high levels in plasma. Since the protein was secreted by the kidneys and metabolized adrenaline, they named it renalase and gave it a closer look.
Four cups a day keeps the doctor away
Improved cardiovascular health and decreased likelihood of liver cancer, Parkinson’s disease and Type II diabetes are all potential benefits of regular coffee consumption, according to the Mayo Clinic. But a new Yale study may have recognized another health benefit: skin cancer protection.Source: Yale Daily News
Heart failure in older breast cancer patients linked to medication
Heart failure is a relatively common complication in older women with breast cancer, but the risk is even higher in those patients treated with adjuvant trastuzumab (Herceptin©), Yale School of Medicine researchers report in the current issue of the Journal of the American College of Cardiology.
Getting it Right (Academic Track): Insights from Brian Coon
Brian Coon received his PhD in Cell Biology where he investigated the links between endocytosis and RhoGTPase & phosphoinositide signaling. In this conversation with Kanika Jain, PhD, Coon shares advice about choosing a career path in academic medicine.